Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
David T. Rubin,Jessica R. Allegretti,Julían Panés,Nicole Shipitofsky,Shadi Yarandi,Kuan-Hsiang Gary Huang,Matthew Germinaro,Rebbecca Wilson,Hongyan Zhang,Jewel Johanns,Brian G. Feagan,Hisamatsu Tadakazu,Gary R. Lichtenstein,Brian Bressler,Laurent Peyrin‐Biroulet,Bruce E Sands,Axel Dignaß,О. Аbrahamovych,Niazy Abu-farsakh,Halyna Afanasieva